Transforming the Future of Cell Therapies

In CellRep, we develop cell reprogramming strategies to increase the functionality of immune cells,
aiming at improving the efficacy of cell therapies.

Cell Reprogramming

End-to-end pipeline from target discovery to preclinical validation of cell reprogramming strategies.

Our Technology and Platform

We have developed an innovative approach to enhance T cell functionality by reprogramming these cells to a rejuvenated state and with improved therapeutic potential.

Our platform includes:

CellRep's image

Target and Drug Discovery

Bioinformatics and AI-driven discovery of druggable targets

CellRep's image

In vitro Screening

Optimized drug screening platform to analyze biomarkers at the single-cell level.

CellRep's image

Preclinical testing

Cutting-edge in vivo models for PoC studies

By integrating these cell reprogramming strategies into the cell therapy manufacturing workflow, more powerful and effective therapies against cancer and other chronic conditions will be delivered to patients in need.